Nimodipine Side Effects

8402584-5 | White Blood Cell Count Abnormal, Hypersensitivity, Hypotension, Influenza Like Illness, Eosinophilia, Arthralgia
on May 17, 2012 Female patient from UNITED STATES , weighting 180.0 lb, was diagnosed with haemolytic uraemic syndrome and was treated with Nimodipine(View Usage). Patient experienced the following unwanted or unexpected effects: white blood cell count abnormal, hypersensitivity, hypotension, influenza like illness, eosinophilia, arthralgia. Nimodipine dosage: . During the same period patient was treated with SOLIRIS (Unk, Q3-4 Weeks) (View Soliris Review and Soliris Label ), ENTOCORT EC (View Entocort Ec Review and Entocort Ec Label ), VERAPAMIL HCL (View Verapamil Hcl Review and Verapamil Hcl Label ), BENADRYL (View Benadryl Review and Benadryl Label ). Patient was hospitalized.

8336566-9 | Caesarean Section, Maternal Exposure During Pregnancy, Premature Delivery
Patient was taking Nimodipine (View Usage). Patient had the following side effects: caesarean section, maternal exposure during pregnancy, premature delivery on Apr 18, 2012 from UNITED STATES Additional patient health information: Female patient , 29 years of age, was diagnosed with aneurysm ruptured and. Nimodipine dosage: . During the same period patient was treated with VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), AZTREONAM (View Aztreonam Review and Aztreonam Label ), LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ), CLINDAMYCIN HYDROCHLORIDE (View Clindamycin Hydrochloride Review and Clindamycin Hydrochloride Label ).

8003217-2 | Blood Creatine Phosphokinase Increased, Hypothyroidism
Adverse event was reported on Dec 16, 2011 by a Female patient taking Nimodipine (View Usage) (Dosage: ) was diagnosed with hyperlipidaemia and. Location: CHINA , 63 years of age, After Nimodipine was administered, patient had the following side effects: blood creatine phosphokinase increased, hypothyroidism. During the same period patient was treated with CYTIDINE DIPHOSPHATE CHOLINE (View Cytidine Diphosphate Choline Review and Cytidine Diphosphate Choline Label ), LESCOL (40 Mg, Qd) (View Lescol Review and Lescol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

7827906-5 | Colitis, Coronary Artery Disease, Pain In Extremity, Aortic Aneurysm, Discomfort, Hypertension
on Oct 07, 2011 Female patient from ARGENTINA , 75 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Nimodipine (View Usage). Patient experienced the following unwanted or unexpected effects: colitis, coronary artery disease (What is coronary artery disease?), pain in extremity, aortic aneurysm (What is aortic aneurysm?), discomfort, hypertension. Nimodipine dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), FORTEO (Unk Unk, Qd) (View Forteo Review and Forteo Label ), ALPLAX (View Alplax Review and Alplax Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), BILETAN (View Biletan Review and Biletan Label ). Patient was hospitalized.


7624075-1 | Convulsion, Tremor, Mental Disorder
on Jul 12, 2011 Male patient from MEXICO , 16 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Nimodipine(View Usage). Patient had the following side effects: convulsion, tremor, mental disorder. Nimodipine dosage: Unk Ukn, Unk. During the same period patient was treated with TRILEPTAL (3 Df, Daily) (View Trileptal Review and Trileptal Label ), LAMICTAL (Unk Ukn, Unk) (View Lamictal Review and Lamictal Label ).

7555576-2 | Pneumonia, Infection, Respiratory Failure, Wound Infection, Dysphagia, Cerebrovascular Accident, Diabetes Mellitus, Dyspnoea, Pyrexia
Patient was taking Nimodipine (View Usage). After Nimodipine was administered, patient had the following side effects: pneumonia (What is pneumonia?), infection (What is infection?), respiratory failure, wound infection, dysphagia, cerebrovascular accident, diabetes mellitus, dyspnoea, pyrexia on Feb 03, 2006 from BRAZIL Additional patient health information: Male patient , 74 years of age, weighting 176.4 lb, was diagnosed with hypertension and. Nimodipine dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), DIOVAN (80 Mg, Qd) (View Diovan Review and Diovan Label ). Patient was hospitalized.

7498526-X | Vasogenic Cerebral Oedema
Adverse event was reported on May 18, 2011 by a Female patient taking Nimodipine (View Usage) (Dosage: 4 Mg, Unk, 2-4 Ml Per Minute) was diagnosed with cerebrovascular spasm and. Location: KOREA, REPUBLIC OF , 24 years of age, Patient experienced the following unwanted or unexpected effects: vasogenic cerebral oedema. Patient was hospitalized.

7497803-6 | Hemiparesis, Somnolence, Vasogenic Cerebral Oedema
on May 18, 2011 Female patient from KOREA, REPUBLIC OF , 40 years of age, was diagnosed with cerebrovascular spasm and was treated with Nimodipine (View Usage). Patient had the following side effects: hemiparesis, somnolence, vasogenic cerebral oedema. Nimodipine dosage: 2 Mg, Unk, 2-4 Ml Per Minute. Patient was hospitalized.

7421144-6 | Syncope
on Apr 07, 2011 Female patient from CHINA , 72 years of age, weighting 154.3 lb, was diagnosed with hypertension, gastric ulcer and was treated with Nimodipine(View Usage). After Nimodipine was administered, patient had the following side effects: syncope. Nimodipine dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ).

5935184-7 | Familial Hemiplegic Migraine, Grand Mal Convulsion
Patient was taking Nimodipine (View Usage). Patient experienced the following unwanted or unexpected effects: familial hemiplegic migraine, grand mal convulsion on Oct 21, 2008 from NORWAY Additional patient health information: Male patient , 16 years of age, was diagnosed with cerebral vasoconstriction, nausea (What is nausea?), migraine (What is migraine?), familial hemiplegic migraine and. Nimodipine dosage: . During the same period patient was treated with VERAPAMIL (View Verapamil Review and Verapamil Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), KETOBEMIDONE (View Ketobemidone Review and Ketobemidone Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ). Patient was hospitalized.

5614954-9 | Renal Failure Acute
Adverse event was reported on Jan 29, 2008 by a Male patient taking Nimodipine (View Usage) (Dosage: ) was diagnosed with metastatic renal cell carcinoma and. Location: SPAIN , 80 years of age, weighting 187.4 lb, Patient had the following side effects: renal failure acute. During the same period patient was treated with SUNITINIB MALATE (View Sunitinib Malate Review and Sunitinib Malate Label ), COZAAR (View Cozaar Review and Cozaar Label ). Patient was hospitalized.

5610608-3 | Blood Pressure Decreased, Breath Sounds Abnormal, Cerebrovascular Accident, Liver Scan Abnormal, Oxygen Saturation Decreased
on Jan 23, 2008 Female patient from UNITED STATES , 63 years of age, weighting 140.0 lb, was treated with Nimodipine (View Usage). After Nimodipine was administered, patient had the following side effects: blood pressure decreased, breath sounds abnormal, cerebrovascular accident, liver scan abnormal, oxygen saturation decreased. Nimodipine dosage: 2 Poked Caps, Under The Tongue 2 Caps, Single, Intravenous. Patient was hospitalized.

5232755-0 | Blood Pressure Decreased, Nodal Arrhythmia
on Feb 06, 2007 Female patient from UNITED STATES , 66 years of age, weighting 71.60 lb, was diagnosed with haemorrhage intracranial and was treated with Nimodipine 60 Mg Bayer(View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, nodal arrhythmia. Nimodipine 60 Mg Bayer dosage: 60 Mg Every 4 Hours Po. Patient was hospitalized.

5025044-0 | Gingival Bleeding, Haemorrhage, Increased Tendency To Bruise
Patient was taking Nimodipine (View Usage). Patient had the following side effects: gingival bleeding, haemorrhage, increased tendency to bruise on Jun 08, 2006 from UNITED STATES Additional patient health information: Female patient , 48 years of age, weighting 140.0 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Nimodipine dosage: 1 Q Am Po. During the same period patient was treated with LAMICTAL (View Lamictal Review and Lamictal Label ), ATIVAN (View Ativan Review and Ativan Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), CYTOMEL (View Cytomel Review and Cytomel Label ), DEXEDRINE (View Dexedrine Review and Dexedrine Label ).

4886868-3 | Asphyxia, Disease Recurrence, Dyspnoea, Heart Rate Increased, Pyrexia, Subarachnoid Haemorrhage
Adverse event was reported on Jan 10, 2006 by a Male patient taking Nimodipine (View Usage) (Dosage: 10 Mg, Total Daily, Intravenous) was diagnosed with prophylaxis, vasospasm and. Location: CHINA , 67 years of age, After Nimodipine was administered, patient had the following side effects: asphyxia, disease recurrence, dyspnoea, heart rate increased, pyrexia, subarachnoid haemorrhage. During the same period patient was treated with CEREBROLYSIN (View Cerebrolysin Review and Cerebrolysin Label ), SODIUM CYTIDINE TRIPHOSPHATE (View Sodium Cytidine Triphosphate Review and Sodium Cytidine Triphosphate Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), AZOSEMIDE (View Azosemide Review and Azosemide Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ).

4869718-0 | Asphyxia, Disease Recurrence, Dyspnoea, Infection, Pyrexia, Subarachnoid Haemorrhage, Tachycardia
on Dec 15, 2005 Male patient from CHINA , 67 years of age, was diagnosed with prophylaxis, vasospasm and was treated with Nimodipine (View Usage). Patient experienced the following unwanted or unexpected effects: asphyxia, disease recurrence, dyspnoea, infection (What is infection?), pyrexia, subarachnoid haemorrhage, tachycardia. Nimodipine dosage: 10 Mg, Total Daily, Intravenous. During the same period patient was treated with CEREBROLYSIN (View Cerebrolysin Review and Cerebrolysin Label ), SODIUM CYTIDINE TRIPHOSPHATE (View Sodium Cytidine Triphosphate Review and Sodium Cytidine Triphosphate Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), AZOSEMIDE (View Azosemide Review and Azosemide Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ).